A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Clinical trial NCT07389499 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07389499
Sponsor: Grit Biotechnology
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

IgA Nephropathy (IgAN)Membranous Nephropathy ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)Refractory Podocytopathy Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits

Start date: 2026-05-30
Primary completion: 2028-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.